Recognition
- Warm AIHA: Associated with systemic lupus erythematosus (SLE), chronic lymphocytic leukemia (CLL), and certain medications (methyldopa, penicillin). IgG antibodies coat RBCs at body temperature. Splenic macrophages partially phagocytose the coated cells, producing spherocytes (small, dense RBCs) that are eventually destroyed. Presents with general anemia symptoms (fatigue, pallor, dyspnea, tachycardia) plus jaundice and splenomegaly.
- Cold AIHA (cold agglutinin disease): Associated with Mycoplasma pneumoniae infection, EBV/mononucleosis, and lymphoma. IgM antibodies bind RBCs in the cooler peripheral circulation (fingers, toes, ears, nose), activating complement and causing intravascular hemolysis. Characteristic finding: Raynaud-like acrocyanosis (bluish discoloration of digits and extremities) triggered by cold exposure. May cause dark urine (hemoglobinuria) after cold episodes.
- Diagnosis: Positive direct antiglobulin test (Coombs test) — the definitive laboratory finding confirming antibodies or complement on the RBC surface.
MT Relevance
- Cold AIHA — temperature management is critical: Keep the treatment room warm. Avoid all cold applications (ice packs, cold stones, cool drafts, cold lubricant). Cold triggers hemolytic episodes in these clients. Warm lubricant before application.
- Warm AIHA: Standard room temperature is acceptable. No special temperature precautions needed.
- General anemia modifications apply: Fatigue management (shorter sessions), semi-reclined or side-lying for clients with dyspnea, slow position transitions (orthostatic vulnerability).
- Corticosteroid awareness: First-line treatment for warm AIHA is corticosteroids (prednisone). Chronic corticosteroid use causes skin fragility, easy bruising, proximal myopathy, and potential osteoporosis — reduce pressure accordingly.
- Immunosuppressant awareness: Clients on azathioprine, rituximab, or other immunosuppressants are infection-prone. Strict hygiene. Reschedule if the therapist is ill.
- Active hemolytic crisis: Rapid RBC destruction with acute anemia, jaundice, dark urine, and hemodynamic instability — defer treatment entirely.
Required Actions
- Cold AIHA: Maintain warm treatment environment. Prohibit cold applications
- Active hemolytic crisis: Defer massage until medically stabilized
- New-onset jaundice, dark urine, and severe fatigue: Refer for hematologic evaluation
Key Takeaways
- AIHA involves autoantibodies against the body's own RBCs — warm type (IgG, body temperature) is more common. Cold type (IgM, < 37°C) triggers hemolysis with cold exposure
- For cold AIHA clients, the treatment room must be warm and all cold modalities are contraindicated
- Positive direct Coombs test is the definitive diagnostic finding
- Corticosteroid use requires pressure modification (skin fragility, bruising, osteoporosis risk)
- Active hemolytic crisis contraindicates massage until the client is medically stabilized